|
"liu c j"的相關文件
顯示項目 136-160 / 1268 (共51頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2022-01-25T03:25:15Z |
Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort study
|
Su T.-H.; Liu C.-J.; Tseng T.-C.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Wu S.-J.; Chen P.-J.; Chen D.-S.; CHI-LING CHEN; Kao J.-H. |
| 臺大學術典藏 |
2022-01-25T03:25:13Z |
Prevalence and clinical implications of IL28B genotypes in Taiwanese patients with chronic hepatitis C
|
Mah Y.-H.; Liu C.-H.; CHI-LING CHEN; Tseng T.-C.; Liu C.-J.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-25T03:25:12Z |
Hyperglycemia combined Helicobacter pylori infection increases risk of synchronous colorectal adenoma and carotid artery plaque
|
Hu K.-C.; Wu M.-S.; Chu C.-H.; Wang H.-Y.; Lin S.-C.; Po H.L.; Bair M.-J.; Liu C.-C.; Su T.-H.; CHI-LING CHEN; Liu C.-J.; Shih S.-C. |
| 臺大學術典藏 |
2022-01-25T03:25:10Z |
Fibrosis-4 Index Helps Identify HBV Carriers with the Lowest Risk of Hepatocellular Carcinoma
|
Tseng T.-C.; Liu C.-J.; Su T.-H.; Yang W.-T.; CHI-LING CHEN; Yang H.-C.; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-25T03:25:10Z |
Synergistic effect of hyperglycemia and Helicobacter pylori infection status on colorectal adenoma risk
|
Hu K.-C.; Wu M.-S.; Chu C.-H.; Wang H.-Y.; Lin S.-C.; Liu S.-C.; Liu C.-C.; Su T.-H.; CHI-LING CHEN; Liu C.-J.; Shih S.-C. |
| 臺大學術典藏 |
2022-01-25T03:25:06Z |
Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection
|
Tseng T.-C.; Liu C.-J.; Su T.-H.; Yang W.-T.; CHI-LING CHEN; Yang H.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-25T03:25:06Z |
Distinct Relapse Rates and Risk Predictors after Discontinuing Tenofovir and Entecavir Therapy
|
Su T.-H.; Yang H.-C.; Tseng T.-C.; Liou J.-M.; Liu C.-H.; CHI-LING CHEN; Chen P.-J.; Chen D.-S.; Liu C.-J.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-25T03:25:04Z |
Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma
|
Su T.-H.; Liu C.-J.; Tseng T.-C.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Wu S.-J.; Chen P.-J.; Chen D.-S.; CHI-LING CHEN; Kao J.-H. |
| 臺大學術典藏 |
2022-01-25T03:25:04Z |
Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection
|
Su T.-H.; Liu C.-J.; Tseng T.-C.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Wu S.-J.; Chen P.-J.; Chen D.-S.; CHI-LING CHEN; Kao J.-H. |
| 臺大學術典藏 |
2022-01-25T03:25:03Z |
Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism
|
Su T.-H.; Yang H.-C.; Tseng T.-C.; Chou S.-W.; Lin C.-H.; Liu C.-H.; Liu C.-J.; CHI-LING CHEN; Kao J.-H. |
| 臺大學術典藏 |
2022-01-25T03:25:03Z |
NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging
|
Su T.-H.; Liao S.-H.; Hong C.-M.; Liu C.-J.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; CHI-LING CHEN; Adhoute X.; Bourli?re M.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-25T03:25:03Z |
Decreased Colorectal Adenoma Risk after Helicobacter pylori Eradication: A Retrospective Cohort Study
|
Hu K.-C.; Wu M.-S.; Chu C.-H.; Wang H.-Y.; Lin S.-C.; Liu C.-C.; Su T.-H.; Liao W.-C.; CHI-LING CHEN; Liu C.-J.; Shih S.-C. |
| 臺大學術典藏 |
2022-01-25T03:25:02Z |
High Level of Hepatitis B Core–Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load
|
Tseng T.-C.; Liu C.-J.; Hsu C.-Y.; Hong C.-M.; Su T.-H.; Yang W.-T.; CHI-LING CHEN; Yang H.-C.; Huang Y.-T.; Fang-Tzu Kuo S.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-25T03:25:01Z |
HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis
|
Tseng T.-C.; Liu C.-J.; Chang C.T.; Su T.-H.; Yang W.-T.; Tsai C.-H.; CHI-LING CHEN; Yang H.-C.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-25T03:25:01Z |
Antiviral therapy against chronic hepatitis C is associated with a reduced risk of oral cancer
|
Su T.-H.; Tseng T.-C.; Liu C.-J.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; CHI-LING CHEN; Kao J.-H. |
| 臺大學術典藏 |
2022-01-25T03:25:00Z |
Relationship between serum gamma-glutamyl transferase level and colorectal adenoma
|
Hong T.-C.; Yang H.-C.; CHI-LING CHEN; Kao J.-H.; Liu C.-J.; Chen M.-J.; Wang H.-Y.; Kuo Y.-C.; Yu L.-Y.; Hu K.-C. |
| 臺大學術典藏 |
2022-01-25T03:24:58Z |
Serum PIVKA-II and alpha-fetoprotein at virological remission predicts hepatocellular carcinoma in chronic hepatitis B related cirrhosis
|
Su T.-H.; Peng C.-Y.; Chang S.-H.; Tseng T.-C.; Liu C.-J.; CHI-LING CHEN; Liu C.-H.; Yang H.-C.; Chen P.-J.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-25T03:24:57Z |
Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load
|
Tseng T.-C.; Liu C.-J.; Yang W.-T.; Hsu C.-Y.; Hong C.-M.; Su T.-H.; Tsai C.-H.; CHI-LING CHEN; Yang H.-C.; Liu C.-H.; Chen H.-H.; Chen P.-J.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T06:05:35Z |
Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Shao Y.-Y.; Wang S.-Y.; Lin S.-M.; Chen K.-Y.; Tseng J.-H.; Ho M.-C.; Lee R.-C.; Liang P.-C.; Liao L.-Y.; Huang K.-W.; Hu J.-T.; Liang J.-D.; Kee K.-M.; Lin C.-L.; Wang C.-K.; Lu S.-N.; Wang J.-H.; Lee W.-C.; Chen C.-H.; Liu C.-J.; Huang Y.-H.; Wang C.-C.; Wang T.-E.; Chuang P.-H.; Dai C.-Y.; CHIUN HSU; Chen S.-C.; Hsieh C.-H.; Diagnosis Group, Systemic Therapy Group |
| 臺大學術典藏 |
2022-01-13T08:45:56Z |
Mining Gut Microbiota From Bariatric Surgery for MAFLD
|
Wu W.-K.; Chen Y.-H.; Lee P.-C.; PO-JEN YANG; Chang C.-C.; Liu K.-L.; Hsu C.-C.; Huang C.-C.; Chuang H.-L.; Sheen L.-Y.; Liu C.-J.; Wu M.-S. |
| 臺大學術典藏 |
2022-01-07T06:05:52Z |
Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial
|
Liu C.-H.; Liu C.-J.; Huang C.-F.; Lin J.-W.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; CHIH-YUAN LEE; Chen S.-I.; Yang S.-S.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Yu M.-L.; Kao J.-H. |
| 國立成功大學 |
2022 |
Serum cytokine/chemokine profiles predict hepatitis B reactivation in HBV/HCV co-infected subjects receiving direct-acting antiviral agents
|
Huang, S.-C.;Cheng, P.-N.;Liu, C.-H.;Yang, H.-C.;Su, T.-H.;Tseng, Tseng T.-C.;Chen, P.-J.;Kao, J.-H.;Liu, C.-J. |
| 國立成功大學 |
2022 |
Ledipasvir/sofosbuvir for HCV genotype 1, 2, 4–6 infection: Real-world evidence from a nationwide registry in Taiwan
|
Lo, C.-C.;Huang, C.-F.;Cheng, P.-N.;Tseng, K.-C.;Chen, Chen C.-Y.;Kuo, H.-T.;Huang, Y.-H.;Tai, C.-M.;Peng, C.-Y.;Bair, M.-J.;Chen, Chen C.-H.;Yeh, M.-L.;Lin, C.-L.;Lin, C.-Y.;Lee, P.-L.;Chong, L.-W.;Hung, C.-H.;Chang, T.S.;Huang, J.-F.;Yang, C.-C.;Hu, J.-T.;Lin, C.-W.;Chen, Chen C.-T.;Wang, C.-C.;Su, W.-W.;Hsieh, T.-Y.;Lin, C.-L.;Tsai, W.-L.;Lee, T.-H.;Chen, G.-Y.;Wang, S.-J.;Chang, Chang C.-C.;Mo, L.-R.;Yang, S.-S.;Wu, Wu W.-C.;Huang, C.-S.;Hsiung, C.-K.;Kao, C.-N.;Tsai, P.-C.;Liu, C.-H.;Lee, M.-H.;Liu, C.-J.;Dai, C.-Y.;Chuang, W.-L.;Lin, H.-C.;Kao, J.-H.;Yu, M.-L.;investigators, TACR |
| 國立成功大學 |
2022 |
Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR)
|
Huang, C.-F.;Tseng, K.-C.;Cheng, P.-N.;Hung, C.-H.;Lo, C.-C.;Peng, C.-Y.;Bair, M.-J.;Yeh, M.-L.;Chen, Chen C.-H.;Lee, P.-L.;Lin, C.-Y.;Kuo, H.-T.;Chen, Chen C.-T.;Yang, C.-C.;Huang, J.-F.;Tai, C.-M.;Hu, J.-T.;Lin, C.-L.;Su, W.-W.;Tsai, W.-L.;Huang, Y.-H.;Cheng, Cheng C.-Y.;Lin, C.-L.;Wang, C.-C.;Yang, S.-S.;Mo, L.-R.;Chen, G.-Y.;Chang, Chang C.-C.;Wang, S.-J.;Huang, C.-S.;Hsieh, T.-Y.;Lin, C.-W.;Lee, T.-H.;Chong, L.-W.;Huang, C.-W.;Chang, S.-N.;Tsai, M.-C.;Hsu, S.-J.;Kao, J.-H.;Liu, C.-J.;Liu, C.-H.;Lin, H.-C.;Lee, M.-H.;Tsai, P.-C.;Dai, C.-Y.;Chuang, W.-L.;Chen, Chen C.-Y.;Yu, M.-L. |
| 國立成功大學 |
2022 |
Sofosbuvir/Velpatasvir for Hepatitis�C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan
|
Cheng, P.-N.;Mo, L.-R.;Chen, Chen C.-T.;Chen, Chen C.-Y.;Huang, C.-F.;Kuo, H.-T.;Lo, C.-C.;Tseng, K.-C.;Huang, Y.-H.;Tai, C.-M.;Peng, C.-Y.;Bair, M.-J.;Chen, Chen C.-H.;Yeh, M.-L.;Lin, C.-L.;Lin, C.-Y.;Lee, P.-L.;Chong, L.-W.;Hung, C.-H.;Chang, T.S.;Huang, J.-F.;Yang, C.-C.;Hu, J.-T.;Lin, C.-W.;Wang, C.-C.;Su, W.-W.;Hsieh, T.-Y.;Lin, C.-L.;Tsai, W.-L.;Lee, T.-H.;Chen, G.-Y.;Wang, S.-J.;Chang, Chang C.-C.;Yang, S.-S.;Wu, Wu W.-C.;Huang, C.-S.;Chou, K.-H.;Kao, C.-N.;Tsai, P.-C.;Liu, C.-H.;Lee, M.-H.;Cheng, Cheng C.-Y.;Tsai, M.-C.;Liu, C.-J.;Dai, C.-Y.;Lin, H.-C.;Kao, J.-H.;Chuang, W.-L.;Yu, M.-L.;investigators, TACR |
顯示項目 136-160 / 1268 (共51頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目
|
